Maheswari Muruganandam
MBBS | Rheumatologist | 20+ years Exp
Medicare Enrolled
2211 Lomas Blvd Ne # 5acc, Albuquerque
New Mexico, 87106-2719
505-272-3840 505-272-4006
Maps & DirectionsMaheswari Muruganandam is a Albuquerque, New Mexico based rheumatologist with 20 years of experience in Rheumatology. She completed her graduation from Other in 2005. She is also affiliated with hospitals like University Of New Mexico Hospital and Unm Sandoval Regional Medical Center. She accepts the Medicare-approved amount. Patients will not be billed for any more than the Medicare deductible and coinsurance. Active license number of Maheswari Muruganandam for Rheumatology is MD2019-0277 in New Mexico.
Maheswari Muruganandam treat joint disease similar to orthopedists but do not perform surgeries. She diagnose and treat diseases of joints, muscle, bones and tendons which includes arthritis, back pain, muscle strains, common athletic injuries and 'collagen' diseases.
Complete Profile:
Maheswari Muruganandam speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
| Specialization: | Rheumatology |
| Credentials: | MBBS |
| Experience: | 20+ years |
| Medical School Attended: | Other |
| Graduation Year: | 2005 |
| Gender: | Female |
| Accepts Medicare Assignment: | Yes |
| Practice Address: | 2211 Lomas Blvd Ne # 5acc, Albuquerque,
New Mexico, 87106-2719 |
| Phone: | 505-272-3840 |
| Fax: | 505-272-4006 |
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
| PAC ID: | 9335410547 |
| Enrollment ID: | I20191003002935 |
| NPI Number: | 1548609852 |
| NPI Enumeration Date: | 19 Jun, 2013 |
| NPI Last Update On: | 26 Sep, 2024 |
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Maheswari Muruganandam are as mentioned below.
| License Number | Specialization | State | Status | |
| MD2019-0277 | Rheumatologist | New Mexico | Primary | |
| 256091 | Internal Medicine | Massachusetts | Secondary | |
| Student in an Organized Health Care Education/Training Program | New Mexico | Secondary | |
Hospital Affiliation:
Surgeons are affiliated to many hospitals whom they worked with in the past or are presently working with. One surgeon can be affiliated to four to five hospitals at a time.
| Hospital Name (CCN) | State | Hospital Type |
| University Of New Mexico Hospital (320001) | Albuquerque, NM | Acute Care Hospital |
| Unm Sandoval Regional Medical Center (320089) | Rio rancho, NM | Acute Care Hospital |
Group Practice:
Group practices are practice of medicine by a group of physicians who share their premises and other resources. Following list states all the group name
with which Maheswari Muruganandam is associated with along with the number of members in that group.
| Organization Name (Group PAC ID) | Members |
| University Of New Mexico Medical Group (4981795267) | 939 |
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
| Address: | 800 Bradbury Dr Se Ste 116,
Albuquerque, New Mexico |
| Zip: | 87106-4310 |
| Phone Number: | 505-272-1476 |
| Fax Number: | 505-272-4006 |
Patients can reach Maheswari Muruganandam at
2211 Lomas Blvd Ne # 5acc, Albuquerque, New Mexico or can
call to book an appointment on 505-272-3840.
Comments/ Reviews:
Patients can read all the reviews posted for Maheswari Muruganandam below. You may also share your own experience like the quality of treatment, behavior, and overall care provided by Maheswari Muruganandam. It will help others make informed decisions.
** Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 December, 2025.